| Date Checked | 2025-12-21 23:37:20 |
|---|---|
| Graham Number | (PB)73.07 vs (PE)54.18 |
| Over / Under Value Percentage | 76.54% vs 102.39% |
| Dividend Yield | 0.21% |
| Dividend Date | 2023-05-12 |
| Symbol | PKI |
| AssetType | Common Stock |
| Name | PerkinElmer Inc |
| Description | PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. |
| CIK | 31791 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Address | 940 WINTER STREET, WALTHAM, MA, US |
| FiscalYearEnd | December |
| LatestQuarter | 2022-12-31 |
| MarketCapitalization | 16495502000 |
| EBITDA | 1286595000 |
| PERatio | 32.14 |
| PEGRatio | 4.018 |
| BookValue | 58.45 |
| DividendPerShare | 0.28 |
| EPS | 4.06 |
| RevenuePerShareTTM | 26.25 |
| ProfitMargin | 0.172 |
| OperatingMarginTTM | 0.26 |
| ReturnOnAssetsTTM | 0.0369 |
| ReturnOnEquityTTM | 0.0706 |
| RevenueTTM | 3311822000 |
| GrossProfitTTM | 2040719000 |
| DilutedEPSTTM | 4.06 |
| QuarterlyEarningsGrowthYOY | -0.324 |
| QuarterlyRevenueGrowthYOY | -0.279 |
| AnalystTargetPrice | 156.26 |
| TrailingPE | 32.14 |
| ForwardPE | 22.52 |
| PriceToSalesRatioTTM | 3.683 |
| PriceToBookRatio | 2.569 |
| EVToRevenue | 4.609 |
| EVToEBITDA | 15.05 |
| Beta | 1.102 |
| 52WeekHigh | 169.73 |
| 52WeekLow | 113.28 |
| 50DayMovingAverage | 129.0 |
| 200DayMovingAverage | 135.24 |
| SharesOutstanding | 126412000 |
| ExDividendDate | 2023-07-20 |
| naga | 0 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:37:20 |
| fresh | 1 |